Emilia Bulaevsky Zychlinsky

Emilia Bulaevsky Zychlinsky

Geschäftsführer bei Exai Bio, Inc.

68 Jahre
Health Technology
Consumer Services
Technology Services

Ursprung des Netzwerks ersten Grades von Emilia Bulaevsky Zychlinsky

EinheitArt der EinheitIndustrie
Private Company Biotechnology 29
6
Holding Company Packaged Software 6

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Emilia Bulaevsky Zychlinsky

UnternehmenSektorVerknüpfte PersonenHauptposition
Medical Specialties

Patrick Arensdorf

President

Biotechnology

Louis C. Bock

John Curnutte

Corporate Officer/Principal

Director/Board Member

Medical Specialties

Andrew Galligan

Director of Finance/CFO

Electrical Products

Andrew Galligan

Director of Finance/CFO

Investment Managers

Lori F. Rafield

Private Equity Investor

EXACT SCIENCES CORPORATION Medical Specialties

David W. Nikka

Chief Operating Officer

CORCEPT THERAPEUTICS INCORPORATED Pharmaceuticals: Major

Andrew Galligan

Director of Finance/CFO

HANSEN MEDICAL, INC. Medical Specialties

Christopher Lowe

Chief Executive Officer

CAREDX, INC Medical Specialties

Jean-Frédéric Viret

Kenneth Charles Fang

Alexander Johnson

Director of Finance/CFO

Corporate Officer/Principal

Corporate Officer/Principal

GENOMIC HEALTH, INC. Medical Specialties

Brian E. Ward

Corporate Officer/Principal

ANTHERA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Christopher Lowe

Director of Finance/CFO

OOMA, INC. Major Telecommunications

Andrew Galligan

Director/Board Member

INTERSECT ENT, INC. Medical/Nursing Services

Patrick Arensdorf

Corporate Officer/Principal

ASANTE SOLUTIONS INC Medical Specialties

Christopher Lowe

Director/Board Member

REBUS HOLDINGS, INC. Biotechnology

Christopher Lowe

Chief Executive Officer

NGM BIOPHARMACEUTICALS, INC. Biotechnology

Jean-Frédéric Viret

Director of Finance/CFO

College/University

Patrick Plewman

John Curnutte

Masters Business Admin

Undergraduate Degree

Boston University College/University

David W. Nikka

Undergraduate Degree

Medical Distributors

Andrew Galligan

Director of Finance/CFO

College/University

Jean-Frédéric Viret

Robert L. Wolfert

Masters Business Admin

Undergraduate Degree

Princeton University College/University

Patrick Arensdorf

Undergraduate Degree

St. Mary's University College/University

Christopher Lowe

Masters Business Admin

University of Colorado Health Sciences Center College/University

Brian E. Ward

Corporate Officer/Principal

University of Michigan College/University

Elizabeth Ann Hutt Pollard

Robert J. Schott

Corporate Officer/Principal

Doctorate Degree

The University of California, San Francisco College/University

Louis C. Bock

Kenneth Charles Fang

Masters Business Admin

Corporate Officer/Principal

California Polytechnic State University (San Luis Obispo) College/University

Christopher Lowe

Undergraduate Degree

Trinity College Dublin College/University

Andrew Galligan

Undergraduate Degree

Medical/Nursing Services

Brian E. Ward

Corporate Officer/Principal

NEVRO CORP. Medical Specialties

Andrew Galligan

Director of Finance/CFO

American College of Medical Genetics & Genomics College/University

Brian E. Ward

Corporate Officer/Principal

Miscellaneous Commercial Services

Brian E. Ward

Chief Operating Officer

Miscellaneous Commercial Services

Andrew Galligan

Corporate Officer/Principal

Medical Specialties

Patrick Arensdorf

President

Miscellaneous

Patrick Arensdorf

Corporate Officer/Principal

Stanford Graduate School of Business College/University

Patrick Arensdorf

Graduate Degree

Medical Specialties

Andrew Galligan

Director/Board Member

Medical Specialties

Mike Pellini

Seema Bhan

Director/Board Member

Private Equity Investor

Statistik

International

Vereinigte Staaten 47
Irland 3
Israel 2
Vereinigtes Königreich 2

Sektoral

Health Technology 26
Consumer Services 13
Health Services 5
Commercial Services 4
Producer Manufacturing 3

Operativ

Director/Board Member 114
Corporate Officer/Principal 52
Director of Finance/CFO 40
Independent Dir/Board Member 32
Chief Executive Officer 30
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT